Abbott ABT has received the FDA’s investigational device exemption (IDE) for its Coronary Intravascular Lithotripsy (“IVL”) system to evaluate the treatment of severe calcification in coronary ...

Johnson & Johnson and Boston Scientific have also recently made moves to sell their own coronary intravascular lithotripsy ...

Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) for its Coronary Intravascular Lithotripsy (IVL) System to ...

The treatment of kidney stones could soon be getting much faster, easier, and safer. Scientists have devised a method of ...

Abbott Laboratories (NYSE:ABT) has caught investor attention with the FDA’s approval of an Investigational Device Exemption (IDE) for its Coronary Intravascular Lithotripsy (IVL) System, a significant ...

Abbott (NYSE: ABT) received FDA investigational device exemption (IDE) approval for its coronary intravascular lithotripsy ...

Initial treatment for biliary colic may focus on ... Extracorporeal shock wave lithotripsy (ESWL) is a noninvasive procedure ...

Extracorporeal shock wave lithotripsy (ESWL) is a widely used, non-invasive nephrolithiasis treatment that is considered safe, with minimal side effects. However, Georg Prange and colleagues from ...

Protect your kidneys, protect your life! Learn about the causes, symptoms, treatment, and prevention of kidney stones this ...

sport.umcg.nl Background and purpose: Extracorporeal shockwave therapy (EWST) has become a popular treatment for patellar tendinopathy. The purpose of this review was to study the effectiveness of ...

Abbott has announced that the U.S. Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) ...